SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-23-002784
Filing Date
2023-01-25
Accepted
2023-01-25 21:00:38
Documents
1
Period of Report
2023-01-23

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3032
  Complete submission text file 0001140361-23-002784.txt   4392
Mailing Address C/O TOBIRA THERAPEUTICS, INC. 701 GATEWAY BOULEVARD, #200 SOUTH SAN FRANCISCO CA 94080
Business Address
Lefebvre Eric (Reporting) CIK: 0001614741 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39303 | Film No.: 23553746

Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Issuer) CIK: 0001746473 (see all company filings)

IRS No.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations